» Articles » PMID: 35315743

Impact of Personal, Subhourly Exposure to Ultrafine Particles on Respiratory Health in Adolescents with Asthma

Overview
Specialty Pulmonary Medicine
Date 2022 Mar 22
PMID 35315743
Authors
Affiliations
Soon will be listed here.
Abstract

Ultrafine particle (UFP; particles <0.1 μm in diameter) concentrations exhibit high spatiotemporal variability; thus, individual-level exposures and health risks are difficult to estimate. To determine the effects of recent UFP exposures on respiratory health outcomes in children and to determine if children with asthma are at increased risk. Personal sampling of UFPs was completed by adolescents in combination with repeated personal spirometry measurements and ecological momentary assessment of respiratory symptoms (wheeze, cough, and/or shortness of breath). We assessed the association between UFP exposures every 30 minutes up to 150 minutes before measuring forced expiratory volume in 1 second (FEV), peak expiratory flow, and respiratory symptoms using mixed-effects models and interaction with asthma diagnosis. Participants ( = 105; 43% with asthma) completed an average of 11 spirometry measurements and 16 symptom responses throughout sampling. After adjustments (maternal education, physical activity, season, and distance to nearest roadway), a 10-fold increase in UFP exposure was significantly associated with a 0.04-L decrease (95% confidence interval [CI], -0.07 to -0.001) in FEV 90 minutes later. Asthma status modified this association in which participants with asthma had significantly lower FEV values in response to UFP exposures 30 minutes earlier than participants without asthma. We found a significant increase in the odds of reporting a respiratory symptom 30 minutes after increased UFP exposure (odds ratio, 1.8; 95% CI, 1.00 to 3.00). Greater UFP exposure conferred deleterious effects on lung function and respiratory symptoms within 90 minutes of exposure and was more pronounced among participants with asthma.

Citing Articles

Integrating Real-Time Air Quality Monitoring, Ecological Momentary Assessment, and Spirometry to Evaluate Asthma Symptoms: Usability Study.

Polivka B, Krueger K, Bimbi O, Huntington-Moskos L, Nyenhuis S, Cramer E JMIR Form Res. 2024; 8:e60147.

PMID: 39388233 PMC: 11502973. DOI: 10.2196/60147.


Participant engagement to develop report-back materials for personal air monitoring.

Ryan P, Wolfe C, Parsons A, Brokamp C, Turner A, Haynes E J Clin Transl Sci. 2023; 7(1):e76.

PMID: 37008611 PMC: 10052429. DOI: 10.1017/cts.2023.30.

References
1.
Hegewald M, Lefor M, Jensen R, Crapo R, Kritchevsky S, Haggerty C . Peak expiratory flow is not a quality indicator for spirometry: peak expiratory flow variability and FEV1 are poorly correlated in an elderly population. Chest. 2007; 131(5):1494-9. DOI: 10.1378/chest.06-2707. View

2.
Medarov B, Pavlov V, Rossoff L . Diurnal variations in human pulmonary function. Int J Clin Exp Med. 2008; 1(3):267-73. PMC: 2592592. View

3.
Buonanno G, Marks G, Morawska L . Health effects of daily airborne particle dose in children: direct association between personal dose and respiratory health effects. Environ Pollut. 2013; 180:246-50. DOI: 10.1016/j.envpol.2013.05.039. View

4.
Desai U, Watson A . Associations Between Ultrafine Particles and Co-Pollutant Concentrations in the Tampa Bay Area. J Environ Health. 2016; 78(9):14-21. View

5.
Park H, Gilbreath S, Barakatt E . Respiratory outcomes of ultrafine particulate matter (UFPM) as a surrogate measure of near-roadway exposures among bicyclists. Environ Health. 2017; 16(1):6. PMC: 5299642. DOI: 10.1186/s12940-017-0212-x. View